Association between Neutrophil-Lymphocyte Ratio (NLR) and Clinical Outcomes among Filipino Patients with End-Stage Renal Disease (ESRD) Secondary to Diabetic Nephropathy on Maintenance Hemodialysis
The incidence of end-stage renal disease (ESRD) is increasing in the Philippines. The presence of diabetes mellitus further worsens ESRD prognosis. The neutrophil-to-lymphocyte ratio (NLR) is a reliable prognostic marker for mortality, but its usefulness as a prognostic biomarker in diabetes patients with chronic kidney disease is yet to be clarified. This study aimed to determine the association between NLR and morbidity among Filipino patients with end-stage renal disease (ESRD) secondary to diabetic nephropathy on maintenance hemodialysis. This was an observational descriptive, prospective cohort study that evaluated outpatient Filipino citizens aged > 18 years diagnosed with ESRD secondary to type 2 diabetes mellitus (T2DM). All patients had good compliance with their hemodialysis regimen (i.e., at least twice weekly dialysis within the past 3 months). The patients were divided into two groups according to the baseline NLR value at a cut-off of 3.5 as the high NLR group (≥3.5) and the low NLR group (<3.5). The cutoff was based on data that a high NLR of ≥3.5 was correlated with increased inflammatory states leading to higher morbidity. Patients were followed up after 6 months, and data on the primary outcome measure of disease occurrence were collected. Of the 63 patients evaluated, the majority (n = 39, 61.9%) had a baseline NLR value of <3.5. The high NLR group included 24 (38.1%) patients; among them, 9 developed diseases. In the low NLR group (n = 39), only 2 patients developed disease. NLR was significantly correlated with clinical disease outcomes (p ≤ 0.05). A baseline NLR of ≥3.5 was associated with disease occurrence. In conclusion, patients with a high baseline NLR have an increased inflammatory state and a higher risk of developing disease conditions than patients with an NLR < 3.5. Thus, the baseline NLR value can be used to predict prognosis in T2DM patients with ESRD.
Cite this paper
Olores, L. A. , Darunday, G. , Polito, E. and Maguad, R. (2023). Association between Neutrophil-Lymphocyte Ratio (NLR) and Clinical Outcomes among Filipino Patients with End-Stage Renal Disease (ESRD) Secondary to Diabetic Nephropathy on Maintenance Hemodialysis. Open Access Library Journal, 10, e465. doi: http://dx.doi.org/10.4236/oalib.1110465.
Depaynos, T., et al. (2019) Quality of Life among End Stage Renal Disease Patients on Hemodialysis and Peritoneal Dialysis in the National Kidney and Transplant Institute. International Journal of Nephrology and Kidney Failure, 5, 1-8.
Catabay, C., et al. (2017) Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients. American Journal of Nephrology, 46, 408-416.
https://doi.org/10.1159/000484177
Neuen, B.L., et al. (2015) Neutrophil–Lymphocyte Ratio Predicts Cardiovascular and All-cause Mortality in Hemodialysis Patients. Renal Failure, 38, 70-76.
https://doi.org/10.3109/0886022X.2015.1104990
Kato, S. et al. (2015) Neutrophil/Lymphocyte Ratio: A Promising Prognostic Marker in Patients with Chronic Kidney Disease. Inflammation and Cell Signaling, 2, 1-5.
Malhorta, R., et al. (2015). Relationship of Neutrophil-to-Lymphocyte Ratio and Serum Albumin Levels with C-Reactive Protein in Hemodialysis Patients: Results from 2 International Cohort Studies. Nephron, 130, 263-270.
https://doi.org/10.1159/000437005
Balta, S., et al. (2016) The Relation between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clinical and Applied Thrombosis/Hemostasis, 22, 405-411.
https://doi.org/10.1177/1076029615569568
Okyay, G., et al. (2013) Neutrophil to Lymphocyte Ratio in Evaluation of Inflammation in Patients with Chronic Kidney Disease. Renal Failure, 35, 29-36.
https://doi.org/10.3109/0886022X.2012.734429
Erdem, E., et al. (2013) Neutrophil to Lymphocyte Ratio in Predicting Short-Term Mortality in Hemodialysis Patients. Journal of Experimental and Clinical Medicine, 30, 129-132.
Imtiaz, F., et al. (2012) Neutrophil Lymphocyte Ratio as a Measure of Systemic Inflammation in Prevalent Chronic Diseases in Asian Population. International Archives of Medicine, 5, 2.
Soleymanian, T., et al. (2017) Clinical Outcomes and Quality of Life in Hemodialysis Diabetic Patients versus Non-Diabetics. Journal of Nephropathology, 6, 81-89.
https://doi.org/10.15171/jnp.2017.14
Turkmen, K., et al. (2012) The Relationship between Neutrophil-to-Lymphocyte Ratio and Inflammation in End-Stage Renal Disease Patients. Renal Failure, 34, 155-159. https://doi.org/10.3109/0886022X.2011.641514
Body Mass Index (BMI) Classification by World Health Organization (WHO).
https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations
Tingting, X., et al. (2017) The Relationship between Neutrophil-to-Lymphocyte Ratio and Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus. Medicine (Baltimore), 96, e8289. https://doi.org/10.1097/MD.0000000000008289
Sherwani, S.I., et al. (2016) Significance of HbA1C Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights, 11, 95-104.
https://doi.org/10.4137/BMI.S38440